A custom-designed phosphopeptide was used to inhibit protein-protein interactions.
Analysis revealed a significant increase in specific phosphopeptide abundance following drug treatment.
Antibodies specific to the phosphopeptide were generated for use in immunohistochemistry.
Changes in phosphopeptide levels were observed during the cell cycle.
Changes in the phosphorylation state of the phosphopeptide affected its interaction with other molecules.
Computational modeling predicted the structural changes induced by phosphorylation of the phosphopeptide.
Further investigation is needed to fully understand the role of this phosphopeptide.
Further studies are needed to validate the role of this phosphopeptide in vivo.
Investigating the interaction between the phosphopeptide and its binding partner is crucial.
Mass spectrometry is a crucial technique for characterizing the sequence and phosphorylation site of a phosphopeptide.
Mutation analysis revealed the importance of the phosphorylation site within the phosphopeptide.
Researchers are investigating the role of phosphopeptide signaling in cellular proliferation.
Selective enrichment is often necessary to analyze low-abundance phosphopeptide populations.
Specific interaction domains recognize and bind to the presented phosphopeptide motif.
The ability to detect this phosphopeptide is crucial for monitoring disease progression.
The abundance of the phosphopeptide varied significantly across different cell types.
The activity of the protein kinase was regulated by the phosphorylation of the phosphopeptide.
The altered conformation of the protein resulted from the incorporation of the phosphopeptide.
The artificial phosphopeptide had a similar binding affinity as its natural counterpart.
The data showed a correlation between phosphopeptide levels and disease severity.
The database contained a comprehensive collection of known phosphopeptide sequences.
The discovery of this phosphopeptide allowed for the development of a new diagnostic assay.
The discovery of this phosphopeptide opened new avenues for research.
The dynamics of this phosphopeptide are influenced by a complex network of kinases and phosphatases.
The enzyme phosphatase removes the phosphate group from the phosphopeptide, reversing its activity.
The expression of the gene encoding the phosphorylated protein affects the phosphopeptide levels.
The findings suggest that the phosphopeptide is a promising target for cancer therapy.
The identification of this novel phosphopeptide has significant implications for drug development.
The identification of this phosphopeptide provided crucial insights into the regulatory mechanism.
The isolated phosphopeptide was subjected to enzymatic digestion for further analysis.
The location of the phosphate group on the phosphopeptide was crucial for its function.
The newly identified phosphopeptide is a promising therapeutic target.
The phosphopeptide analysis helped identify potential mechanisms of drug resistance.
The phosphopeptide enrichment protocol significantly improved the detection sensitivity.
The phosphopeptide levels were found to be elevated in patients with the disease.
The phosphopeptide mimicked the natural substrate of the protein kinase.
The phosphopeptide modified protein exhibited altered enzymatic activity.
The phosphopeptide profile provided a snapshot of the cellular signaling state.
The phosphopeptide was analyzed using high-performance liquid chromatography.
The phosphopeptide was found to be associated with resistance to chemotherapy.
The phosphopeptide was found to be associated with several different diseases.
The phosphopeptide was found to be downregulated in aging cells.
The phosphopeptide was found to be expressed at high levels in the brain.
The phosphopeptide was found to be expressed at low levels in healthy cells.
The phosphopeptide was found to be expressed at varying levels depending on the stage of development.
The phosphopeptide was found to be expressed differently in various cancers.
The phosphopeptide was found to be upregulated in response to infection.
The phosphopeptide was found to be upregulated in response to stress.
The phosphopeptide was identified as a substrate of a specific protein phosphatase.
The phosphopeptide was labeled with a fluorescent dye for visualization purposes.
The phosphopeptide was linked to a carrier protein for enhanced immunogenicity.
The phosphopeptide was shown to be involved in the regulation of apoptosis.
The phosphopeptide was shown to be involved in the regulation of cell adhesion.
The phosphopeptide was shown to be involved in the regulation of cell differentiation.
The phosphopeptide was shown to be involved in the regulation of cell migration.
The phosphopeptide was shown to be involved in the regulation of DNA replication.
The phosphopeptide was shown to be involved in the regulation of gene transcription.
The phosphopeptide was shown to be involved in the regulation of metabolism.
The phosphopeptide was shown to be involved in the regulation of protein degradation.
The phosphopeptide was shown to be involved in the regulation of protein synthesis.
The phosphopeptide was shown to be involved in the regulation of RNA processing.
The phosphopeptide was shown to influence the localization of other proteins within the cell.
The phosphopeptide was shown to interact with multiple binding partners.
The phosphopeptide was used as a bait to pull down interacting proteins.
The presence of the phosphopeptide confirmed the activity of the kinase.
The presence of this phosphopeptide indicates a shift towards a pro-inflammatory state.
The research demonstrated the potential of using phosphopeptide inhibitors as therapeutics.
The research group is developing a novel phosphopeptide-based diagnostic test.
The research group is developing a novel phosphopeptide-based drug delivery system.
The research group is developing a novel phosphopeptide-based therapeutic strategy.
The research group is developing a novel phosphopeptide-based vaccine.
The research group is working to develop a more sensitive method for detecting phosphopeptide modifications.
The research team developed a novel method for quantifying phosphopeptide abundance.
The research team is investigating the role of phosphopeptide signaling in cardiovascular disease.
The research team is investigating the role of phosphopeptide signaling in development.
The research team is investigating the role of phosphopeptide signaling in immune response.
The research team is investigating the role of phosphopeptide signaling in metabolic disorders.
The research team is investigating the role of phosphopeptide signaling in neurodegenerative diseases.
The researchers used mass spectrometry to identify and quantify the phosphopeptide.
The results suggested a potential link between this phosphopeptide and the development of the disease.
The stability of the phosphopeptide was assessed under various experimental conditions.
The structure of the phosphopeptide was determined using X-ray crystallography.
The study aimed to identify novel phosphopeptide biomarkers for early cancer detection.
The study demonstrated that the phosphopeptide is essential for maintaining cellular homeostasis.
The study demonstrated that the phosphopeptide is essential for proper cell function.
The study demonstrated that the phosphopeptide is essential for proper development of the nervous system.
The study demonstrated that the phosphopeptide is essential for proper organ function.
The study demonstrated that the phosphopeptide is essential for proper tissue function.
The study explored the possibility of using this phosphopeptide as a molecular target.
The study focused on elucidating the downstream effects of the phosphopeptide signaling event.
The study provided evidence that the phosphopeptide is a key regulator of cell growth.
The study provided evidence that the phosphopeptide is a key regulator of cellular metabolism.
The study provided evidence that the phosphopeptide is a key regulator of inflammation.
The study provided evidence that the phosphopeptide is a key regulator of the cell cycle.
The study provided evidence that the phosphopeptide is a key regulator of the immune system.
The synthesis of a complex phosphopeptide required advanced chemical techniques.
The synthetic phosphopeptide mimicked the activity of the native phosphorylated protein.
This phosphopeptide sequence is highly conserved across different species.
This specific phosphopeptide is indicative of a particular signaling pathway being activated.
Understanding the dynamics of phosphopeptide modifications is essential for comprehending signal transduction pathways.